T1	SNP 695 699;737 740	Five SNP
T2	Entity 700 703	IL6
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T3	Interaction 750 760	haplotypes
E1	Interaction:T3 Entity:T1
T4	Entity 746 749	IL6
R2	SNP_coupled_gene Arg1:E1 Arg2:T4	
T6	Entity 614 619;634 660	women southwestern United States
R3	Population_assignment Arg1:T1 Arg2:T6	
T5	Entity 454 472	non-Hispanic white
T7	Entity 519 543	Hispanic/Native American
R4	Member Arg1:T6 Arg2:T7	
R5	Member Arg1:T6 Arg2:T5	
T8	Spec 238 246	evaluate
T9	SNP 247 264	genetic variation
T10	Entity 272 275	IL6
R6	SNP_coupled_gene Arg1:T9 Arg2:T10	
T11	Association 286 290	risk
E2	Association:T11 snp_int:T9 bc:T12
R7	Speculation_marker Arg1:E2 Arg2:T8	
T12	Cancer 294 307	breast cancer
T13	Entity 914 928	postmenopausal
T14	Entity 935 967	not recently exposed to hormones
T15	Entity 973 978	AG/GG
T16	SNP 992 1001	rs1800797
R8	Genotype Arg1:T16 Arg2:T15	
T17	Entity 1003 1007	-596
T18	Entity 1007 1010	A>G
R9	SNP_location Arg1:T16 Arg2:T17	
R10	Nucleotide_substitution Arg1:T16 Arg2:T18	
R11	Risk_Factor Arg1:T16 Arg2:T13	
R12	Risk_Factor Arg1:T16 Arg2:T14	
T19	Entity 1020 1025	GC/CC
T20	SNP 1039 1048	rs1800795
T21	Entity 1050 1054	-174
T22	Entity 1054 1057	G>C
R13	Genotype Arg1:T20 Arg2:T19	
R14	SNP_location Arg1:T20 Arg2:T21	
R15	Nucleotide_substitution Arg1:T20 Arg2:T22	
R16	Risk_Factor Arg1:T20 Arg2:T13	
R17	Risk_Factor Arg1:T20 Arg2:T14	
T23	Level 1059 1072	significantly
T24	Effect_Type 1073 1080	reduced
T25	Association 1081 1085	risk
E3	Association:T25 snp_int:T20 snp_int2:T16 bc:T26
A1	Effect_Type E3 Decrease
A2	Level E3 High
R18	Effect_type_marker Arg1:E3 Arg2:T24	
R19	Level_marker Arg1:E3 Arg2:T23	
T26	Cancer 1089 1102	breast cancer
R20	Population_assignment Arg1:T16 Arg2:T6	
R21	Population_assignment Arg1:T20 Arg2:T6	
R22	Member Arg1:T1 Arg2:T16	
R23	Member Arg1:T1 Arg2:T20	
T27	SNP 1993 2002	rs1800796
T28	SNP 2006 2013	-572G>C
T29	Entity 2006 2010	-572
T30	Entity 2010 2013	G>C
R24	Nucleotide_substitution Arg1:T28 Arg2:T30	
R25	SNP_location Arg1:T28 Arg2:T29	
T32	SNP 1712 1720	genotype
T33	Interaction 1725 1734	haplotype
E4	Interaction:T33 
T34	Entity 1708 1711	IL6
R26	SNP_coupled_gene Arg1:T32 Arg2:T34	
R27	SNP_coupled_gene Arg1:E4 Arg2:T34	
T35	Level 1735 1748	significantly
T36	Entity 1865 1897	not recently exposed to hormones
R29	Member Arg1:T1 Arg2:T32	
R30	Member Arg1:E1 Arg2:E4	
T37	Therapeutic_response 1749 1757	modified
E5	Therapeutic_response:T37 Agent:E4 Agent2:T32 Theme:T31
R32	Level_marker Arg1:E5 Arg2:T35	
A3	Level E5 High
T39	Entity 1782 1789	aspirin
R28	Risk_Factor Arg1:T27 Arg2:T36	
R31	Risk_Factor Arg1:T28 Arg2:T36	
T38	Level 1818 1826	greatest
T40	Therapeutic_response 1834 1846	modification
E6	Therapeutic_response:T40 Agent:T27 Agent2:T28
A4	Level E6 High
R34	Level_marker Arg1:E6 Arg2:T38	
R33	Member Arg1:T32 Arg2:T28	
R35	Member Arg1:T32 Arg2:T27	
R36	Risk_Factor Arg1:T32 Arg2:T39	
R37	Risk_Factor Arg1:E4 Arg2:T39	
T31	Cancer 1794 1807	breast cancer
R38	Risk_Factor Arg1:T27 Arg2:T39	
R39	Risk_Factor Arg1:T28 Arg2:T39	
